Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule
- PMID: 36831344
- PMCID: PMC9953844
- DOI: 10.3390/cancers15041000
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule
Abstract
This study aims to evaluate the reliability of qualitative and semiquantitative parameters of 18F-FDG PET-CT, and eventually a correlation between them, in predicting the risk of malignancy in patients with solitary pulmonary nodules (SPNs) before the diagnosis of lung cancer. A total of 146 patients were retrospectively studied according to their pre-test probability of malignancy (all patients were intermediate risk), based on radiological features and risk factors, and qualitative and semiquantitative parameters, such as SUVmax, SUVmean, TLG, and MTV, which were obtained from the FDG PET-CT scan of such patients before diagnosis. It has been observed that visual analysis correlates well with the risk of malignancy in patients with SPN; indeed, only 20% of SPNs in which FDG uptake was low or absent were found to be malignant at the cytopathological examination, while 45.45% of SPNs in which FDG uptake was moderate and 90.24% in which FDG uptake was intense were found to be malignant. The same trend was observed evaluating semiquantitative parameters, since increasing values of SUVmax, SUVmean, TLG, and MTV were observed in patients whose cytopathological examination of SPN showed the presence of lung cancer. In particular, in patients whose SPN was neoplastic, we observed a median (MAD) SUVmax of 7.89 (±2.24), median (MAD) SUVmean of 3.76 (±2.59), median (MAD) TLG of 16.36 (±15.87), and a median (MAD) MTV of 3.39 (±2.86). In contrast, in patients whose SPN was non-neoplastic, the SUVmax was 2.24 (±1.73), SUVmean 1.67 (±1.15), TLG 1.63 (±2.33), and MTV 1.20 (±1.20). Optimal cut-offs were drawn for semiquantitative parameters considered predictors of malignancy. Nodule size correlated significantly with FDG uptake intensity and with SUVmax. Finally, age and nodule size proved significant predictors of malignancy. In conclusion, considering the pre-test probability of malignancy, qualitative and semiquantitative parameters can be considered reliable tools in patients with SPN, since cut-offs for SUVmax, SUVmean, TLG, and MTV showed good sensitivity and specificity in predicting malignancy.
Keywords: 18F-FDG; MTV; PET; SUVmax; SUVmean; TLG; solitary pulmonary nodule.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial.Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1898-1907. doi: 10.1007/s00259-018-4016-1. Epub 2018 May 7. Eur J Nucl Med Mol Imaging. 2018. PMID: 29736699
-
Solitary Pulmonary Nodule: Morphological Effects on Metabolic Activity Assessment.Mol Imaging Radionucl Ther. 2019 Sep 6;28(3):112-119. doi: 10.4274/mirt.galenos.2019.65707. Mol Imaging Radionucl Ther. 2019. PMID: 31507144 Free PMC article.
-
The Multicenter Italian Trial Assesses the Performance of FDG-PET /CT Related to Pre-Test Cancer Risk in Patients with Solitary Pulmonary Nodules and Introduces a Segmental Thoracic Diagnostic Strategy.Curr Radiopharm. 2020;13(3):243-248. doi: 10.2174/1874471013666200318142210. Curr Radiopharm. 2020. PMID: 32186274 Free PMC article.
-
18F-FDG PET/CT diagnostic performance in solitary and multiple pulmonary nodules detected in patients with previous cancer history: reports of 182 nodules.Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):429-436. doi: 10.1007/s00259-018-4226-6. Epub 2018 Dec 8. Eur J Nucl Med Mol Imaging. 2019. PMID: 30535767
-
Prognostic value of 18F-FDG PET/CT in patients with advanced or metastatic non-small-cell lung cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis.Front Immunol. 2022 Nov 17;13:1014063. doi: 10.3389/fimmu.2022.1014063. eCollection 2022. Front Immunol. 2022. PMID: 36466905 Free PMC article.
Cited by
-
18F-FDG PET/CT metabolic parameters can semi-quantitatively evaluate the nature of the heart and pericardial masses: a retrospective study.Sci Rep. 2024 Jul 15;14(1):16316. doi: 10.1038/s41598-024-67336-8. Sci Rep. 2024. PMID: 39009884 Free PMC article.
References
-
- Liu W.K., Li X.D., Quan J.T., Ouyang X., Zheng H. Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma. Nan Fang Yi Ke Da Xue Xue Bao. 2015;35:114–116. - PubMed
LinkOut - more resources
Full Text Sources